Acute Exacerbation and Proposed Criteria for Progressive Pulmonary Fibrosis in Patients with Fibrotic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis
Respiration · 2023
DOI: 10.1159/000533312 ↗Kurz gefasst
Fachartikel in der Zeitschrift Respiration, 2023. Verfasst von Ryo Okuda und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis, Alveolitis, Extrinsic Allergic. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
Background
Acute exacerbation (AE) occasionally develops in the course of fibrotic hypersensitivity pneumonitis (HP).
Objective
The aim of the study was to compare AE of fibrotic HP with that of idiopathic pulmonary fibrosis (IPF).
Methods
Consecutive patients with pathologically confirmed fibrotic HP and IPF diagnosed based on a multidisciplinary discussion were included in the analysis. AE in patients with fibrotic HP and IPF was evaluated retrospectively.
Results
This study included 309 and 160 patients with fibrotic HP and IPF, respectively. Their 50% survival times were 96.1 and 78.0 months, respectively (hazard ratio [HR]: 0.54 [95% confidence interval, CI: 0.36–0.77], log-rank test; p < 0.001). Notably, the cumulative AE rates of fibrotic HP were 3% at 1 year and 10% at 3 years. Moreover, the corresponding rates of IPF were 8% at 1 year and 20% at 3 years (HR: 0.66 [95% CI: 0.45–0.93], log-rank test; p = 0.034). The 90-day survival rates from the AE onset of fibrotic HP and IPF were 75% and 64%, respectively (HR: 0.51 [95% CI: 0.31–0.83], log-rank test; p = 0.006). The respiratory function test on the physiological criteria of progressive pulmonary fibrosis (PPF) was a predictor of AE in fibrotic HP. However, the high-resolution CT (HRCT) changes in the criteria of PPF were not. Nevertheless, both the physiological and radiological criteria of PPF were a predictor of AE of IPF.
Conclusion
AE of fibrotic HP has a lesser prognostic effect than that of IPF. HRCT criteria for PPF were not a risk factor for AE in patients with fibrotic HP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan.
- Department of Pathology, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan.
- Department of Data Science, National Cancer Center Hospital East, Chiba, Japan.
- Department of Radiology, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan.
Zitieren
APA
Okuda, R., Takemura, T., Misumi, T., Nagasawa, R., Iwasawa, T., Baba, T., Hagiwara, E., & Ogura, T. (2023). Acute Exacerbation and Proposed Criteria for Progressive Pulmonary Fibrosis in Patients with Fibrotic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis. Respiration. https://doi.org/10.1159/000533312
Vancouver
Okuda R, Takemura T, Misumi T, Nagasawa R, Iwasawa T, Baba T, et al. Acute Exacerbation and Proposed Criteria for Progressive Pulmonary Fibrosis in Patients with Fibrotic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis. Respiration. 2023. doi:10.1159/000533312
BibTeX
@article{Okuda2023,
author = {Okuda, Ryo and Takemura, Tamiko and Misumi, Toshihiro and Nagasawa, Ryo and Iwasawa, Tae and Baba, Tomohisa and Hagiwara, Eri and Ogura, Takashi},
title = {Acute Exacerbation and Proposed Criteria for Progressive Pulmonary Fibrosis in Patients with Fibrotic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis},
journal = {Respiration},
year = {2023},
doi = {10.1159/000533312}
}
EUVIMED